ClinConnect ClinConnect Logo
Search / Trial NCT05513872

Overcoming Nicotine Dependence to Enable Quitting

Launched by RUSH UNIVERSITY MEDICAL CENTER · Aug 23, 2022

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Tobacco Smoking Cessation Nicotine Dependence Nicotine Replacement Therapy Behavioral Treatment

ClinConnect Summary

This clinical trial, titled "Overcoming Nicotine Dependence to Enable Quitting," is exploring new approaches to help smokers who aren't ready to quit just yet. The study focuses on a concept called "practice quitting," which involves trying to go without smoking for a few hours or days without the pressure of committing to stop for good. Researchers want to see if this practice can encourage more permanent quitting down the line. They will compare two different types of counseling—one that encourages practice quitting and another called Motivational Interviewing—and provide some participants with a four-week supply of nicotine replacement therapy (like lozenges and patches) to see how these strategies work.

To participate, individuals need to be at least 18 years old, smoke at least five cigarettes a day, and not be planning to quit within the next month. They should also be motivated to either quit or reduce their smoking within the next six months. Participants will need to be comfortable using a smartphone for study activities and must be residents of the continental United States. This trial aims to offer new insights into helping smokers take their first steps towards quitting, even if they aren't ready to stop completely right now.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Eligible participants will be males and females who:
  • 1. are 18 years or older
  • 2. report current daily cigarette smoking (≥ 5 cigarettes per day)
  • 3. are not planning to quit in the next 30 days
  • 4. are not currently engaged in smoking cessation treatment
  • 5. are motivated to quit or engage in a non-cessation goal (i.e., reduce smoking, learn more about treatment options, and/ or try out skills to change smoking) in the next 6 months
  • 6. are English speaking
  • 7. reside in the continental United States
  • 8. have access to a smartphone that can be used to complete study procedures
  • Exclusion Criteria:
  • Participants will be excluded for daily vaping/ electronic cigarettes use (i.e., use for ≥ 25 days within past 30 days) and any FDA contraindications for NRT use if they:
  • 1. are pregnant/breastfeeding
  • 2. had recent cardiovascular trauma such as myocardial infarction
  • 3. had a stroke within the past 3 months

About Rush University Medical Center

Rush University Medical Center is a leading academic medical institution located in Chicago, Illinois, dedicated to advancing healthcare through innovative research and clinical trials. As a sponsor of numerous clinical studies, Rush focuses on translating scientific discoveries into effective treatments and improving patient outcomes across a variety of medical disciplines. With a commitment to excellence in patient care, education, and research, Rush leverages its state-of-the-art facilities and a robust network of specialists to conduct comprehensive trials that adhere to the highest ethical and regulatory standards. Through collaboration with a diverse patient population, Rush aims to enhance the understanding of diseases and develop novel therapeutic strategies.

Locations

Chicago, Illinois, United States

Patients applied

0 patients applied

Trial Officials

Amanda Mathew, PhD

Principal Investigator

Rush University Medical Center

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials